Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial

Zhonghua yi xue za zhi

Volumn 82, Issue 14, 2002, Pages 941-944

  Zhang, Zhenxin ^a   Wang, Xinde ^a   Chen, Qingtang ^a   Shu, Liang ^a   Wang, Jizuo ^a   Shan, Guangliang ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; HUPERZINE A; SESQUITERPENE;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; SESQUITERPENES;

EID: 0037173785     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)